Is there a higher prevalence of methicillin-resistant Staphylococcus aureus (MRSA) or vancomycin-resistant Enterococcus (VRE) colonization in patients with antibiotic allergy labels?
Authors:
- 1 June 2020
- journal article
- research article
- Published by Elsevier in American Journal of Infection Control
- Vol. 48 (6) , 663-667
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The prevalence and reliability of self-reported penicillin allergy in a community hospitalInternational Journal of General Medicine, 2013
- Antimicrobial stewardshipʼs new weapon? A review of antibiotic allergy and pathways to ‘de-labeling’Current Opinion in Infectious Diseases, 2013
- Long-Term Risk for Readmission, Methicillin-Resistant Staphylococcus aureus (MRSA) Infection, and Death among MRSA-Colonized VeteransAntimicrobial Agents and Chemotherapy, 2013
- Twenty-five years of shared life with vancomycin-resistant enterococci: is it time to divorce?Journal of Antimicrobial Chemotherapy, 2012
- Identifying the Risk Factors for Hospital-Acquired Methicillin-Resistant Staphylococcus aureus (MRSA) Infection among Patients Colonized with MRSA on AdmissionInfection Control & Hospital Epidemiology, 2012
- Time interval of increased risk for Clostridium difficile infection after exposure to antibioticsJournal of Antimicrobial Chemotherapy, 2011
- Clinical and Economic Outcomes Attributable to Health Care–Associated Sepsis and PneumoniaArchives of internal medicine (1960), 2010
- Hospital and Societal Costs of Antimicrobial‐Resistant Infections in a Chicago Teaching Hospital: Implications for Antibiotic StewardshipClinical Infectious Diseases, 2009
- Secular Trends of Hospitalization With Vancomycin-Resistant Enterococcus Infection in the United States, 2000–2006Infection Control & Hospital Epidemiology, 2009
- The Risk of Infection after Nasal Colonization with Staphylococcus AureusThe American Journal of Medicine, 2008